{
    "2014-04-22": [
        "EARNINGS ALERT: Amgen Q1 EPS $1.87 ex-items vs. $1.94 Est.; Q1 Revs. $4.52B vs. $4.76B Est.",
        "Amgen earnings miss with Kyprolis, not good for $LGND due to royalty on Kyprolis",
        "$AMGN misses the Estimize EPS Consensus by 9c and the Estimize Revenue Consensus by $248.58M",
        "$IBB up 3% ahead of health, biotech earnings season including $GILD, $ISRG, and $AMGN",
        "Small-cap stocks breaking 52-wk high prices include $FTI, $IVZ, $AMGN, $GRPN"
    ]
}